Sabra Healthcare REIT Inc. (NASDAQ:SBRA) has earned an average rating of “Hold” from the seventeen analysts that are covering the firm. Two investment analysts have rated the stock with a sell rating, nine have issued a hold rating and six have issued a buy rating on the company. The average 12-month price target among analysts that have issued ratings on the stock in the last year is $22.86.
Several equities analysts have issued reports on SBRA shares. TheStreet raised Sabra Healthcare REIT from a “hold” rating to a “buy” rating in a report on Tuesday, August 2nd. BTIG Research started coverage on Sabra Healthcare REIT in a report on Thursday, August 25th. They set a “neutral” rating on the stock. JMP Securities reaffirmed a “hold” rating on shares of Sabra Healthcare REIT in a report on Friday, September 9th. Cantor Fitzgerald reaffirmed a “buy” rating on shares of Sabra Healthcare REIT in a report on Friday, August 19th. Finally, Citigroup Inc. raised their price objective on Sabra Healthcare REIT from $22.00 to $24.00 and gave the stock a “neutral” rating in a report on Wednesday, August 17th.
Large investors have recently made changes to their positions in the stock. Vanguard Group Inc. increased its stake in Sabra Healthcare REIT by 3.0% in the second quarter. Vanguard Group Inc. now owns 10,251,855 shares of the company’s stock worth $211,547,000 after buying an additional 302,868 shares during the last quarter. BlackRock Fund Advisors increased its stake in Sabra Healthcare REIT by 3.5% in the second quarter. BlackRock Fund Advisors now owns 4,373,529 shares of the company’s stock worth $90,248,000 after buying an additional 148,542 shares during the last quarter. Forward Management LLC increased its stake in Sabra Healthcare REIT by 0.4% in the second quarter. Forward Management LLC now owns 2,383,000 shares of the company’s stock worth $49,173,000 after buying an additional 10,024 shares during the last quarter. BlackRock Institutional Trust Company N.A. increased its stake in Sabra Healthcare REIT by 2.8% in the first quarter. BlackRock Institutional Trust Company N.A. now owns 2,218,952 shares of the company’s stock worth $44,579,000 after buying an additional 59,712 shares during the last quarter. Finally, State Street Corp increased its stake in Sabra Healthcare REIT by 2.5% in the second quarter. State Street Corp now owns 1,347,503 shares of the company’s stock worth $27,808,000 after buying an additional 32,672 shares during the last quarter. Hedge funds and other institutional investors own 92.14% of the company’s stock.
Sabra Healthcare REIT (NASDAQ:SBRA) opened at 23.07 on Monday. The company has a 50-day moving average price of $24.62 and a 200-day moving average price of $22.32. The firm has a market cap of $1.51 billion, a PE ratio of 27.56 and a beta of 1.05. Sabra Healthcare REIT has a 12-month low of $14.92 and a 12-month high of $26.40.
Sabra Healthcare REIT (NASDAQ:SBRA) last issued its quarterly earnings data on Monday, August 1st. The company reported $0.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.58 by $0.03. The company had revenue of $74.20 million for the quarter, compared to analyst estimates of $56.04 million. Sabra Healthcare REIT had a return on equity of 6.27% and a net margin of 24.63%. The business’s quarterly revenue was up 31.1% compared to the same quarter last year. During the same quarter last year, the company posted $0.53 earnings per share. On average, equities analysts predict that Sabra Healthcare REIT will post $2.28 earnings per share for the current year.
About Sabra Healthcare REIT
Sabra Health Care REIT, Inc is a real estate investment trust. The Company owns and invests in real estate serving the healthcare industry. The Company’s segment is investments in healthcare-related real estate properties. Its primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector.
Receive News & Ratings for Sabra Healthcare REIT Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT Inc. and related companies with MarketBeat.com's FREE daily email newsletter.